Oncology nurses play essential roles in the emerging field of cardio-oncology, which aims to protect patients’ heart function ...

At only age 28, the newlywed and busy teacher initially dismissed her symptoms. As her cough and fatigue worsened, she ...

Dr. Moghanaki joins a prestigious board of lung cancer experts committed to attracting top researchers to the field of lung ...

ProCure Proton Therapy Center marks its 13th anniversary this March, celebrating a legacy of state-of-the-art technology with a patient-centered approach in cancer care. Since 2012, ProCure has helped ...

The Food and Drug Administration (FDA) has approved Imfinzi (durvalumab) for adults with limited-stage small cell lung cancer ...

A woman has revealed her shock at being diagnosed with cancer and cured of it within the same day. April Boudreau, from Texas ...

As an expert explained in an interview with CURE, we may be in the midst of a “new era” for small cell lung cancer research.

A York County business owner is sharing his story of hope after completing an innovative cancer treatment at WellSpan York Hospital. John Grim has been battling prostate cancer for nearly seven years, ...

Learn how new research and clinical trials at Memorial Sloan Kettering Cancer Center (MSK) have helped 32-year-old Giancarlo ...

Sarcopenia influences toxicity and survival in non-small cell lung cancer, and sarcopenia assessment can be factored into ...

Cancer is a complex condition marked by the uncontrolled growth of cells in the body. When this process begins in the lungs, ...

AstraZeneca’s Imfinzi (durvalumab) has been approved in the European Union (EU) as monotherapy for the treatment of adults with limited-stage small cell lung cancer (LS-SCLC) whose disease has not ...